awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37559275-36F46B0B-0F2F-41CD-AA82-A05C61BBD4C7
Q37559275-36F46B0B-0F2F-41CD-AA82-A05C61BBD4C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37559275-36F46B0B-0F2F-41CD-AA82-A05C61BBD4C7
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.
P2860
Q37559275-36F46B0B-0F2F-41CD-AA82-A05C61BBD4C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37559275-36F46B0B-0F2F-41CD-AA82-A05C61BBD4C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a6cb01ef29d760a28d0ffa0572193a27676ee4e
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.